Terms: = Lung cancer AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776 AND Treatment
53 results:
1. [Construction and Validation of Prediction Models of Risk Factors for Early Death in Patients With Metastatic Melanoma].
Li S; Li J; Yang Q; Yin C; Liu B
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):367-374. PubMed ID: 38645854
[TBL] [Abstract] [Full Text] [Related]
2. Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage lung Adenocarcinoma.
Tai MC; Bantis LE; Parhy G; Kato T; Tanaka I; Chow CW; Fujimoto J; Behrens C; Hase T; Kawaguchi K; Fahrmann JF; Ostrin EJ; Yokoi K; Chen-Yoshikawa TF; Hasegawa Y; Hanash SM; Wistuba II; Taguchi A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397007
[TBL] [Abstract] [Full Text] [Related]
3. Patterns of Anticoagulation Use and All-Cause of Mortality in cancer Patients with Atrial Fibrillation.
Han X; Yang X; Hidru TH; Wang C; Xia Y
Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):244-253. PubMed ID: 38088911
[TBL] [Abstract] [Full Text] [Related]
4. Novel nomogram for predicting survival in advanced non-small cell lung cancer receiving anti-PD-1 plus chemotherapy with or without antiangiogenic therapy.
Wu Y; Lv C; Lin M; Hong Y; Du B; Yao N; Zhu Y; Ji X; Li J; Lai J
Front Immunol; 2023; 14():1297188. PubMed ID: 38022521
[TBL] [Abstract] [Full Text] [Related]
5. Identification of risk factors and prediction models for secondary malignant neoplasms (SMNs)-free survival and SMNs-specific survival in testicular cancer survivors.
Fu H; Talluri S; Rai S; Liang L; Trivedi J; Ankem MK
World J Urol; 2023 Sep; 41(9):2413-2420. PubMed ID: 37530808
[TBL] [Abstract] [Full Text] [Related]
6. Effects of CALM intervention on neutrophil-to-lymphocyte ratio (NLR), fear of cancer recurrence and quality of life in patients with lung cancer.
Zhao J; Wang M; Huang R; Xu J; Gan C; Yu S; Tang L; Yao S; Li W; Cheng H
Support Care Cancer; 2023 Jul; 31(7):447. PubMed ID: 37414980
[TBL] [Abstract] [Full Text] [Related]
7. Erlotinib plus bevacizumab versus erlotinib alone in patients with
Deng W; Wang K; Jiang Y; Li D; Bao C; Luo J; Liu L; Huang B; Kong J
BMJ Open; 2022 Aug; 12(8):e062036. PubMed ID: 35985780
[TBL] [Abstract] [Full Text] [Related]
8. Fast investigative lung cancer pathway and endobronchial ultrasound procedure supported by rapid on-site evaluation.
Khan KA; Narine N; Bailey S; Shelton D; Rana D
Diagn Cytopathol; 2022 Sep; 50(9):436-441. PubMed ID: 35808981
[TBL] [Abstract] [Full Text] [Related]
9. Apigenin in cancer prevention and therapy: A systematic review and meta-analysis of animal models.
Singh D; Gupta M; Sarwat M; Siddique HR
Crit Rev Oncol Hematol; 2022 Aug; 176():103751. PubMed ID: 35752426
[TBL] [Abstract] [Full Text] [Related]
10. Patterns and Trends in Receipt of Opioids Among Patients Receiving treatment for cancer in a Large Health System.
Sabik LM; Eom KY; Sun Z; Merlin JS; Bulls HW; Moyo P; Pruskowski JA; van Londen GJ; Rosenzweig M; Schenker Y
J Natl Compr Canc Netw; 2022 Mar; 20(5):460-467.e1. PubMed ID: 35231900
[TBL] [Abstract] [Full Text] [Related]
11. Concurrent chemoradiotherapy with cisplatin + S-1 versus cisplatin + other third-generation agents for locally advanced non-small-cell lung cancer: a meta-analysis of individual participant data.
Taniguchi Y; Okamoto H; Shimokawa T; Sasaki T; Seto T; Niho S; Ohe Y; Saigusa Y
BMC Pulm Med; 2022 Jan; 22(1):31. PubMed ID: 35000608
[TBL] [Abstract] [Full Text] [Related]
12. Atrial resection for T4 non-small cell lung cancer with left atrium involvement: a systematic review and meta-analysis of survival.
Hamouri S; Alrabadi N; Syaj S; Abushukair H; Ababneh O; Al-Kraimeen L; Al-Sous M; Hecker E
Surg Today; 2023 Mar; 53(3):279-292. PubMed ID: 35000034
[TBL] [Abstract] [Full Text] [Related]
13. Cost-effectiveness of nivolumab in patients with NSCLC in the United States.
Chaudhary MA; Lubinga SJ; Smare C; Hertel N; Penrod JR
Am J Manag Care; 2021 Aug; 27(8):e254-e260. PubMed ID: 34460179
[TBL] [Abstract] [Full Text] [Related]
14. A novel method for the quantification of anlotinib in human plasma using two-dimensional liquid chromatography.
Li Z; Chen H; Shi J; Wang F; Liu Y
Biomed Chromatogr; 2021 Dec; 35(12):e5218. PubMed ID: 34291843
[TBL] [Abstract] [Full Text] [Related]
15. Validation Study of the International Association for the Study of lung cancer Histologic Grading System of Invasive lung Adenocarcinoma.
Rokutan-Kurata M; Yoshizawa A; Ueno K; Nakajima N; Terada K; Hamaji M; Sonobe M; Menju T; Date H; Morita S; Haga H
J Thorac Oncol; 2021 Oct; 16(10):1753-1758. PubMed ID: 33905897
[TBL] [Abstract] [Full Text] [Related]
16. cancer Stage, treatment, and Survival Among Transgender Patients in the United States.
Jackson SS; Han X; Mao Z; Nogueira L; Suneja G; Jemal A; Shiels MS
J Natl Cancer Inst; 2021 Sep; 113(9):1221-1227. PubMed ID: 33704460
[TBL] [Abstract] [Full Text] [Related]
17. Imaging Biomarkers of Hypothyroidism on lung cancer Screening CT.
Watane GV; Hammer MM
Curr Probl Diagn Radiol; 2021; 50(6):807-810. PubMed ID: 33468363
[TBL] [Abstract] [Full Text] [Related]
18. Incidence of bone metastases in patients with organ-specific cancers: A nationwide population-based cohort study.
Shih JT; Yeh TT; Wang SH; Shen PH; Wang CC; Chien WC; Chung CH; Wu CC
Int J Clin Pract; 2021 May; 75(5):e13997. PubMed ID: 33400307
[TBL] [Abstract] [Full Text] [Related]
19. Association of Programmed Cell Death Ligand 1 Expression Status With Receipt of Immune Checkpoint Inhibitors in Patients With Advanced Non-Small Cell lung cancer.
Leapman MS; Presley CJ; Zhu W; Soulos PR; Adelson KB; Miksad RA; Boffa DJ; Gross CP
JAMA Netw Open; 2020 Jun; 3(6):e207205. PubMed ID: 32511721
[TBL] [Abstract] [Full Text] [Related]
20. Impact of Site-Specific Metastases on Surgical Value and Survival among Metastatic Colorectal cancer Patients.
Zong Z; Zhou TC; Tang FX; Tian HK; Wang A; Yi CH
Am Surg; 2020 Mar; 86(3):220-227. PubMed ID: 32223801
[TBL] [Abstract] [Full Text] [Related]
[Next]
